| CASH FLOWS FROM OPERATING ACTIVITIES |
| Net income |
4.13B |
| Adjustments to reconcile net income to net cash provided by operating activities: |
| Realized investment (gains) losses, net |
-4.13B |
| Policy charges and fee income |
-1.42B |
| Interest credited to policyholders' account balances |
3.17B |
| Depreciation and amortization |
402M |
| Gains on trading account assets supporting insurance liabilities, net |
-361M |
| Change in: |
| Deferred policy acquisition costs |
-391M |
| Future policy benefits and other insurance liabilities |
7.67B |
| Other trading account assets |
-54M |
| Income taxes |
| Other, net |
-216M |
| Cash flows from operating activities |
17.04B |
| Proceeds from the sale/maturity/prepayment of: |
| Fixed maturities, available for sale |
36.42B |
| Fixed maturities, held to maturity |
205M |
| Trading account assets supporting insurance liabilities and other trading account assets |
24.72B |
| Equity securities, available for sale |
2.8B |
| Commercial mortgage and other loans |
4.52B |
| Policy loans |
1.73B |
| Other long-term investments |
457M |
| Short-term investments |
35.73B |
| Payments for the purchase/origination of: |
| Fixed maturities, available for sale |
-49.47B |
| Fixed maturities, held to maturity |
| Trading account assets supporting insurance liabilities and other trading account assets |
-26.05B |
| Equity securities, available for sale |
-2.41B |
| Commercial mortgage and other loans |
-6.01B |
| Policy loans |
-1.4B |
| Other long-term investments |
-1.54B |
| Short-term investments |
-33.2B |
| Acquisition of Subsidiaries, net of cash acquired |
-532M |
| Other, net |
228M |
| Cash flows used in investing activities |
-13.08B |
| CASH FLOWS FROM FINANCING ACTIVITIES |
| Policyholders' account deposits |
22.21B |
| Policyholders' account withdrawals |
-17.51B |
| Net change in securities sold under agreements to repurchase and cash collateral for loaned securities |
488M |
| Cash dividends paid on Common Stock |
-939M |
| Net change in financing arrangements (maturities of 90 days or less) |
516M |
| Common Stock reissued for exercise of stock options |
112M |
| Proceeds from the issuance of debt (maturities longer than 90 days) |
1.45B |
| Repayments of debt (maturities longer than 90 days) |
-1.45B |
| Excess tax benefits from share-based payment arrangements |
4M |
| Other, net |
-611M |
| Cash flows from (used in) financing activities |
2.8B |
| Effect of foreign exchange rate changes on cash balances |
360M |
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
7.12B |
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR |
17.61B |
| CASH AND CASH EQUIVALENTS, END OF PERIOD |
24.73B |
| NON-CASH TRANSACTIONS DURING THE PERIOD |
| Treasury Stock shares issued for stock-based compensation programs |
